This content is machine translated Breast Cancer On the trail of triple-negative breast cancer Triple-negative breast cancer (TNBC) is a disease with an often aggressive course and a poor prognosis compared to other subtypes of breast cancer. It accounts for around 10-15% of all…
View Post 2 min This content is machine translated HSP90 inhibition A new therapeutic approach for breast cancer In an initial phase II study in metastatic breast cancer, the HSP90 inhibitor ganetespib has shown promising antitumor activity in HER2-positive and triple-negative breast cancer (TNBC). Due to the favorable…